NASDAQ Companies

Continued momentum in upliFT-D trial of PBFT02 for the treatment of patients with frontotemporal dementia (FTD) with granulin mutations (GRN) […]

NEW HAVEN, Conn., March 04, 2024 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new […]

SHANGHAI, China, March 04, 2024 (GLOBE NEWSWIRE) — ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility […]

— Significant step toward reimbursement for the only medical device approved in the U.S. for treatment of gait deficit due […]

SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ:IRTC), a leading digital health care company focused […]

Complete Remission rate of 64% and Overall Response Rate of 73% demonstrated in highly refractory patients Durability of clinical activity […]

BELGRADE, Mont., March 04, 2024 (GLOBE NEWSWIRE) — Bridger Aerospace Group Holdings, Inc. (“Bridger” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), […]

— Generated $19.5 million in fourth quarter and $28.0 million of full year 2023 net revenue from sales of LUMRYZ™ […]

SAN CARLOS, Calif., March 04, 2024 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on […]

NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) — Carlyle Secured Lending, Inc. (“CSL”) (NASDAQ: CGBD) today announced that Justin Plouffe […]